These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31089260)

  • 1. H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas.
    Cao T; Jiang Y; Wang Z; Zhang N; Al-Hendy A; Mamillapalli R; Kallen AN; Kodaman P; Taylor HS; Li D; Huang Y
    Oncogene; 2019 Jul; 38(27):5356-5366. PubMed ID: 31089260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.
    Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
    J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3'RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1.
    Jokinen V; Mehine M; Reinikka S; Khamaiseh S; Ahvenainen T; Äyräväinen A; Härkki P; Bützow R; Pasanen A; Vahteristo P
    Genes Chromosomes Cancer; 2023 Jan; 62(1):27-38. PubMed ID: 35822448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.
    Wu X; Serna VA; Thomas J; Qiang W; Blumenfeld ML; Kurita T
    Cancer Res; 2017 Dec; 77(24):6891-6901. PubMed ID: 29055020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
    Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
    Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.
    Yang Q; Mas A; Diamond MP; Al-Hendy A
    Reprod Sci; 2016 Feb; 23(2):163-75. PubMed ID: 25922306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
    Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
    Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
    Commandeur AE; Styer AK; Teixeira JM
    Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas.
    Moyo MB; Parker JB; Chakravarti D
    Nat Commun; 2020 Feb; 11(1):1019. PubMed ID: 32094355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenomic and enhancer dysregulation in uterine leiomyomas.
    Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
    Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.
    Mehine M; Kaasinen E; Heinonen HR; Mäkinen N; Kämpjärvi K; Sarvilinna N; Aavikko M; Vähärautio A; Pasanen A; Bützow R; Heikinheimo O; Sjöberg J; Pitkänen E; Vahteristo P; Aaltonen LA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1315-20. PubMed ID: 26787895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.
    Peng Y; Laser J; Shi G; Mittal K; Melamed J; Lee P; Wei JJ
    Mol Cancer Res; 2008 Apr; 6(4):663-73. PubMed ID: 18403645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.
    Yang Q; Laknaur A; Elam L; Ismail N; Gavrilova-Jordan L; Lue J; Diamond MP; Al-Hendy A
    Reprod Sci; 2016 Oct; 23(10):1314-25. PubMed ID: 27036951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.
    Berta DG; Kuisma H; Välimäki N; Räisänen M; Jäntti M; Pasanen A; Karhu A; Kaukomaa J; Taira A; Cajuso T; Nieminen S; Penttinen RM; Ahonen S; Lehtonen R; Mehine M; Vahteristo P; Jalkanen J; Sahu B; Ravantti J; Mäkinen N; Rajamäki K; Palin K; Taipale J; Heikinheimo O; Bützow R; Kaasinen E; Aaltonen LA
    Nature; 2021 Aug; 596(7872):398-403. PubMed ID: 34349258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations.
    Xie J; Ubango J; Ban Y; Chakravarti D; Kim JJ; Wei JJ
    Genes Chromosomes Cancer; 2018 Oct; 57(10):485-494. PubMed ID: 29790226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
    Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
    Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas.
    Maekawa R; Sato S; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Takaki E; Nakai A; Sugino N
    PLoS One; 2013; 8(6):e66632. PubMed ID: 23818951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
    Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
    Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guizhi Fuling Capsule inhibits uterine fibroids growth by modulating Med12-mediated Wnt/β-Catenin signaling pathway.
    Chen L; Chen H; Yang Q; Jiang Y; Liu L; Yu H; Chen Y; Li J; Chen N; Wang H; Wang Q
    J Ethnopharmacol; 2022 May; 290():115115. PubMed ID: 35181487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA MIAT Modulates the Extracellular Matrix Deposition in Leiomyomas by Sponging MiR-29 Family.
    Chuang TD; Quintanilla D; Boos D; Khorram O
    Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34491311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.